These CACs man, they really hustlin' out here:
So big news story today right:
Company cures Ebola virus in monkeys
Key paragraphs:
Now, peep game:
http://www.tekmira.com/partners/partnerships.php
.....So, they got contracts from both the government and one of the most prominent pharmaceutical companies in 2010 to find a cure for Ebola and a way to deliver the vaccine. Then there's suddenly an Ebola outbreak in 2014, and suddenly we have a cure?
Truly, the
hustle is immaculate. Now Mofasa and 'em will have to sign those trade agreements with the US instead of China if they don't want to die from Ebola
So big news story today right:
Company cures Ebola virus in monkeys
Key paragraphs:
An experimental drug cured monkeys infected with a close relative of Ebola virus even after they began showing symptoms — the first time such a drug has been shown to work so many days after infection.
The drug, being developed by a Canadian company called Tekmira, saved the lives of 16 monkeys given highly lethal doses of Marburg virus, the researchers report in the journal Science Translational Medicine. Five monkeys that did not get the drug all died within a week...
The drug uses bits of genetic material called small interfering RNAs, or siRNAs for short. Viruses kills cells by invading them and taking over their machinery to force them to pump out copy after copy of virus. This drug doesn’t prevent infection, but stops the virus from replicating by attaching to its RNA. “It messes up the blueprint for making more virus particles,” Geisbert said. “It keeps it from reading the recipe and making virus proteins.”...
Now, peep game:
http://www.tekmira.com/partners/partnerships.php
Bristol-Myers Squibb
In 2010, Tekmira entered into a multi-year, target validation agreement with Bristol-Myers Squibb. Tekmira will supply LNP formulations of siRNA provided by Bristol-Myers Squibb to silence target genes of interest. Bristol-Myers paid Tekmira $3-million concurrent with the signing of the agreement. Tekmira announced a further expansion of the collaboration to include broader applications of its LNP technology and additional target validation work.
Joint Project Manager Medical Countermeasure Systems (JPM-MCS) U.S. Department of Defense (DoD)
In 2010, Tekmira signed a $140-million contract with the DoD to advance an RNAi therapeutic, which utilized our LNP technology, to treat Ebola virus infection. In 2013, the collaboration was expanded to include significant advances in LNP formulation technology, including a new LNP formulation that was more potent, the ability to be able to lyophilize (freeze-dry) LNP formulations and an LNP formulation that can be administered subcutaneously. In January 2014, Tekmira commenced TKM-Ebola Phase I clinical trial. JPM-MCS, a component of the Joint Program Executive Office for Chemical and Biological Defense, aims to provide U.S. military forces and the nation with safe, effective, and innovative medical solutions to counter chemical, biological, radiological, and nuclear threats. JPM-MCS facilitates the advanced development and acquisition of medical countermeasures and systems to enhance U.S. biodefense response capability (aka extortion via germ warfare).
.....So, they got contracts from both the government and one of the most prominent pharmaceutical companies in 2010 to find a cure for Ebola and a way to deliver the vaccine. Then there's suddenly an Ebola outbreak in 2014, and suddenly we have a cure?
![patrice :patrice: :patrice:](https://www.thecoli.com/styles/default/xenforo/smilies/patrice.png)
![tumblr_n4r3jfQBL21rz36j2o8_100.png](https://33.media.tumblr.com/ab4125747fb936234d6aa5a4147076c5/tumblr_n4r3jfQBL21rz36j2o8_100.png)
![tumblr_n4r3jfQBL21rz36j2o7_100.png](https://38.media.tumblr.com/a57036f66d7bb46350dd302653bfe9ab/tumblr_n4r3jfQBL21rz36j2o7_100.png)